 Colitis, Ulcerative
"Colitis, Ulcerative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
| Descriptor ID |
D003093
|
| MeSH Number(s) |
C06.405.205.265.231 C06.405.205.731.249 C06.405.469.158.188.231 C06.405.469.432.249
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Colitis, Ulcerative".
Below are MeSH descriptors whose meaning is more specific than "Colitis, Ulcerative".
This graph shows the total number of publications written about "Colitis, Ulcerative" by people in this website by year, and whether "Colitis, Ulcerative" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 1 | 0 | 1 | | 1982 | 2 | 1 | 3 | | 1983 | 1 | 0 | 1 | | 1984 | 2 | 0 | 2 | | 1985 | 3 | 0 | 3 | | 1986 | 4 | 0 | 4 | | 1987 | 2 | 0 | 2 | | 1988 | 4 | 0 | 4 | | 1989 | 5 | 0 | 5 | | 1990 | 5 | 1 | 6 | | 1991 | 3 | 2 | 5 | | 1992 | 6 | 0 | 6 | | 1993 | 5 | 2 | 7 | | 1994 | 4 | 2 | 6 | | 1995 | 8 | 0 | 8 | | 1996 | 5 | 3 | 8 | | 1997 | 3 | 0 | 3 | | 1998 | 8 | 2 | 10 | | 1999 | 4 | 2 | 6 | | 2000 | 6 | 0 | 6 | | 2001 | 8 | 2 | 10 | | 2002 | 6 | 1 | 7 | | 2003 | 13 | 1 | 14 | | 2004 | 14 | 1 | 15 | | 2005 | 7 | 5 | 12 | | 2006 | 17 | 1 | 18 | | 2007 | 12 | 4 | 16 | | 2008 | 12 | 2 | 14 | | 2009 | 12 | 3 | 15 | | 2010 | 9 | 0 | 9 | | 2011 | 23 | 3 | 26 | | 2012 | 13 | 1 | 14 | | 2013 | 16 | 1 | 17 | | 2014 | 8 | 0 | 8 | | 2015 | 8 | 2 | 10 | | 2016 | 23 | 5 | 28 | | 2017 | 17 | 4 | 21 | | 2018 | 12 | 0 | 12 | | 2019 | 16 | 5 | 21 | | 2020 | 7 | 1 | 8 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Colitis, Ulcerative" by people in Profiles.
-
Somineni HK, Nagpal S, Venkateswaran S, Cutler DJ, Okou DT, Haritunians T, Simpson CL, Begum F, Datta LW, Quiros AJ, Seminerio J, Mengesha E, Alexander JS, Baldassano RN, Dudley-Brown S, Cross RK, Dassopoulos T, Denson LA, Dhere TA, Iskandar H, Dryden GW, Hou JK, Hussain SZ, Hyams JS, Isaacs KL, Kader H, Kappelman MD, Katz J, Kellermayer R, Kuemmerle JF, Lazarev M, Li E, Mannon P, Moulton DE, Newberry RD, Patel AS, Pekow J, Saeed SA, Valentine JF, Wang MH, McCauley JL, Abreu MT, Jester T, Molle-Rios Z, Palle S, Scherl EJ, Kwon J, Rioux JD, Duerr RH, Silverberg MS, Zwick ME, Stevens C, Daly MJ, Cho JH, Gibson G, McGovern DPB, Brant SR, Kugathasan S. Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease. Am J Hum Genet. 2021 03 04; 108(3):431-445.
-
Narula N, Aruljothy A, Alshahrani AA, Fadida M, Al-Saedi M, Marshall JK, Rubin DT, Christensen B. Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission. Aliment Pharmacol Ther. 2020 12; 52(11-12):1676-1682.
-
Glick LR, Cifu AS, Feld L. Ulcerative Colitis in Adults. JAMA. 2020 Sep 22; 324(12):1205-1206.
-
Loftus EV, Feagan BG, Panaccione R, Colombel JF, Sandborn WJ, Sands BE, Danese S, D'Haens G, Rubin DT, Shafran I, Parfionovas A, Rogers R, Lirio RA, Vermeire S. Long-term safety of vedolizumab for inflammatory bowel disease. Aliment Pharmacol Ther. 2020 10; 52(8):1353-1365.
-
Rosen MH, Axelrad J, Hudesman D, Rubin DT, Chang S. Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature. Inflamm Bowel Dis. 2020 06 18; 26(7):971-973.
-
Rubin DT, Abreu MT, Rai V, Siegel CA. Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting. Gastroenterology. 2020 Jul; 159(1):6-13.e6.
-
Akiyama S, Traboulsi C, Rai V, Rubin DT. Re: 18F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial. Eur J Nucl Med Mol Imaging. 2020 09; 47(10):2247.
-
Cohen RD, Bhayat F, Blake A, Travis S. The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-marketing Data. J Crohns Colitis. 2020 Feb 10; 14(2):192-204.
-
Park KT, Ehrlich OG, Allen JI, Meadows P, Szigethy EM, Henrichsen K, Kim SC, Lawton RC, Murphy SM, Regueiro M, Rubin DT, Engel-Nitz NM, Heller CA. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation. Inflamm Bowel Dis. 2020 01 01; 26(1):1-10.
-
Ollech JE, Dwadasi S, Rai V, Peleg N, Normatov I, Israel A, Sossenheimer PH, Christensen B, Pekow J, Dalal SR, Sakuraba A, Cohen RD, Rubin DT. Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis. Aliment Pharmacol Ther. 2020 03; 51(6):637-643.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|